Structures by: Chandrakantha B.
Total: 16
5-Dimethylamino-<i>N</i>,<i>N</i>-dimethyl-2-nitrobenzamide
C11H15N3O3
Acta Crystallographica Section E (2009) 65, 6 o1342
a=7.8581(2)Å b=7.2921(2)Å c=10.5183(3)Å
α=90.00° β=104.6630(10)° γ=90.00°
<i>N</i>,<i>N</i>-Bis(2,6-difluorobenzyl)-1,3,4-thiadiazol-2-amine
C16H11F4N3S
Acta Crystallographica Section E (2009) 65, 9 o2166-o2167
a=32.6678(6)Å b=5.85150(10)Å c=7.8140(2)Å
α=90° β=90° γ=90°
1-Dibromomethyl-4-methoxy-2-nitrobenzene
C8H7Br2NO3
Acta Crystallographica Section E (2009) 65, 9 o2193-o2194
a=7.95910(10)Å b=11.1949(2)Å c=12.2509(2)Å
α=106.2850(10)° β=99.6910(10)° γ=102.4010(10)°
Ethyl 1-<i>tert</i>-butyl-5-phenyl-1<i>H</i>-pyrazole-4-carboxylate
C16H20N2O2
Acta Crystallographica Section E (2010) 66, 9 o2228
a=9.0665(2)Å b=9.3351(2)Å c=10.5408(3)Å
α=110.4500(10)° β=113.9870(10)° γ=97.645(2)°
Ethyl 1,5-diphenyl-1<i>H</i>-pyrazole-4-carboxylate
C18H16N2O2
Acta Crystallographica Section E (2010) 66, 9 o2282-o2283
a=9.2015(8)Å b=10.4638(9)Å c=16.9332(15)Å
α=97.515(2)° β=104.605(2)° γ=104.578(2)°
4-(1,2,4-Triazol-1-yl)aniline
C8H8N4
Acta Crystallographica Section E (2011) 67, 1 o164
a=5.54880(10)Å b=7.3656(2)Å c=19.5477(5)Å
α=90.00° β=99.416(2)° γ=90.00°
5-[(4-Methoxybenzyl)sulfanyl]-2-methyl-1,3,4-thiadiazole
C11H12N2OS2
Acta Crystallographica Section E (2011) 67, 1 o163
a=14.7765(4)Å b=8.6916(3)Å c=9.7339(3)Å
α=90.00° β=96.4770(10)° γ=90.00°
2-Methyl-5-[(3-methyl-4-nitrobenzyl)sulfanyl]-1,3,4-thiadiazole
C11H11N3O2S2
Acta Crystallographica Section E (2011) 67, 1 o205-o206
a=13.8210(14)Å b=4.5720(5)Å c=19.7929(19)Å
α=90.00° β=90.00° γ=90.00°
2-Chloro-4-nitro-1<i>H</i>-imidazole
C3H2ClN3O2
Acta Crystallographica Section E (2010) 66, 7 o1828-o1829
a=5.905(2)Å b=10.033(4)Å c=9.150(3)Å
α=90.00° β=105.180(8)° γ=90.00°
4-(<i>o</i>-Tolyl)piperazin-1-ium chloride
C11H17N2,Cl
Acta Crystallographica Section E (2011) 67, 11 o3115
a=8.1572(2)Å b=11.2821(3)Å c=12.4256(3)Å
α=90.00° β=90.00° γ=90.00°
2,6-Dichloro-3-nitropyridine
C5H2Cl2N2O2
Acta Crystallographica Section E (2011) 67, 7 o1785
a=7.9021(8)Å b=19.166(2)Å c=11.0987(9)Å
α=90.00° β=122.072(5)° γ=90.00°
4-(3-Chlorophenyl)-3-[(2,6-difluorobenzyl)sulfanyl]-5-(3,4,5- trimethoxyphenyl)-4<i>H</i>-1,2,4-triazole
C24H20ClF2N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3422-o3423
a=9.9867(2)Å b=21.5140(3)Å c=11.9793(2)Å
α=90.00° β=117.1970(10)° γ=90.00°
1-Cyclohexyl-5-(4-methoxyphenyl)-1<i>H</i>-pyrazole-4-carboxylic acid
C17H20N2O3
Acta Crystallographica Section E (2011) 67, 12 o3513
a=12.0722(9)Å b=12.7180(9)Å c=11.7739(8)Å
α=90.00° β=118.6980(10)° γ=90.00°
Ethyl 1-cyclohexyl-5-(4-methoxyphenyl)-1<i>H</i>-pyrazole-4-carboxylate
C19H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3460-o3461
a=6.8959(7)Å b=11.0858(7)Å c=12.0142(12)Å
α=100.690(2)° β=93.1070(10)° γ=95.3540(10)°
4-(4-Bromophenyl)-1-(2,6-difluorobenzyl)-3-(3,4,5-trimethoxyphenyl)-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C24H20BrF2N3O3S
Acta Crystallographica Section E (2012) 68, 1 o89
a=17.6694(18)Å b=15.5299(16)Å c=18.0855(19)Å
α=90.00° β=102.955(2)° γ=90.00°
3-Aminoquinoline
C9H8N2
Acta Crystallographica Section E (2012) 68, 11 o3155
a=7.6223(3)Å b=7.6289(3)Å c=12.6967(4)Å
α=90.00° β=90.00° γ=90.00°